Frontiers Production Office*
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
An erratum on
Immunotherapy for Glioblastoma: Current Progress and Challenges
by Yu MW and Quail DF (2021). Front. Immunol. 12:676301. doi: 10.3389/fimmu.2021.676301
Due to a production error, there was an error in the Article Title. The final “s” of “Challenges” was missed from the end of the title.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: glioblastoma, brain cancer, immunotherapy, tumor microenvironment, resistance to therapy
Citation: Frontiers Production Office (2021) Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges. Front. Immunol. 12:782687. doi: 10.3389/fimmu.2021.782687
Received: 24 September 2021; Accepted: 24 September 2021;
Published: 07 October 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn